Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7645884 | Chemical compositions for authenticatable polymers and articles, and authentication methods thereof Disclosed are compositions comprising at least one [benzo[4,5]imidazo(heterocycle)] compound, said [benzo[4,5]imidazo(heterocycle)] compound selected from the group consisting of structures I and II, wherein R1 a... | 01/12/2010 |
| 7473785 | Photoconductive members A compound comprising a tetrahalobenzamidazolebenzene or a bis(tetrahalophenyl)biphenylbisimidazole of the alternative following formulas or dimers thereof wherein each of R1, R2, R3, R... | 01/06/2009 |
| 7442716 | 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors The invention encompasses novel compounds of Formula I or pharmaceutically acceptable salts thereof. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful to t... | 10/28/2008 |
| 7439369 | Method and system for hydrogen evolution and storage A method and system for storing and evolving hydrogen employ chemical compounds that can be hydrogenated to store hydrogen and dehydrogenated to evolve hydrogen. A catalyst lowers the energy required for storing and evolving hydrogen. The method and system can provi... | 10/21/2008 |
| 7419995 | N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of tumors. Combinatorial libraries composed of compounds represented by Formula (I) or benzimidazol... | 09/02/2008 |
| 7371870 | Benzimidazolone compound There are provided benzimidazolone compounds that provide a plurality of hues from a single structural formula, and are useful as pigments that offer superior dispersibility in binder resins, as well as benzimidazolone compounds that are useful as pigments, and show... | 05/13/2008 |
| 7365209 | Nitrogen heterocycle biaryls for osteoporosis and other diseases Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: | 04/29/2008 |
| 7303591 | Composition comprising at least one mixed dye comprising at least two chromophores of (hetero) aromatic nitro or cyclic azine type, dyeing process, and mixed dyes A dye composition comprising at least one mixed dye comprising at least two chromophore chosen from azine and (hetero)aromatic nitro compounds, optionally associated with at least one chromophore chosen from methine and carbonyl compounds; a process for dyeing kerat... | 12/04/2007 |
| 7300471 | Composition comprising at least one mixed dye based on at least one chromophore of azo or tri(hetero) arylmethane type, dyeing process and mixed dyes. Disclosed herein are a dye composition comprising at least one mixed dye comprising at least one chromophore chosen from chromophores of the azo family and the tri(hetero)arylmethane family; and the mixed dyes. Further disclosed herein are a process for dyeing kerat... | 11/27/2007 |
| 7288121 | Composition comprising at least one mixed dye comprising at least one chromophore chosen from compounds of the methine family and/or the carbonyl family, dyeing process and kit, and mixed dyes The present invention relates to a dye composition including at least one mixed dye containing at least one chromophore of methine or carbonyl type or their combinations. The invention furthermore relates to a process for dyeing keratin fibers, especially human kera... | 10/30/2007 |
| 7279496 | Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands Compounds of the formula (I) in which R1, R2, R3 and R4 are as defined in Claim 1, are ligands of the nicotinic acetylcholine receptor and/or serotonergic ligands and are suitable for the prophylaxis or treatment of... | 10/09/2007 |
| 7279495 | Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control The invention relates to compounds of the general formula wherein R1, R2, R3, R4, R5, R6, R7, X, Y and a have the significances given i... | 10/09/2007 |
| 7262305 | Anisotropic films based on 1,8-naphthoylene-1′,2′-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making Optically anisotropic films based on sulfoderivatives of 1,8-naphthoylene-1′,2′-benzimidazole are disclosed. These compounds form stable lyotropic liquid crystal systems that exhibit excellent optical properties with films that are significantly thinner that the... | 08/28/2007 |
| 7230113 | Chemical compositions for authenticatable polymers and articles, and authentication methods thereof Disclosed are compositions comprising at least one [benzo[4,5]imidazo(heterocycle)] compound, said [benzo[4,5]imidazo(heterocycle)] compound selected from the group consisting of structures I and II, wherein R | 06/12/2007 |
| 7201779 | Dye composition comprising at least one direct dye containing mixed chromophores The invention relates to a dye composition comprising a direct dye consisting of different chromophores, the dye having a particular L*a*b* value. The invention also relates to the dyeing process using this composition and to the use of this composition for d... | 04/10/2007 |
| 7193089 | Process for manufacture of telmisartan A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1′-methylbenzimidazol-2′-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4â... | 03/20/2007 |
| 7172633 | Lightening dye composition comprising at least one cationic direct dye containing mixed chromophores The present invention relates to a lightening dye composition comprising, in a suitable dyeing medium, an oxidizing agent, an alkaline agent in an amount such that the pH of the composition is greater than 7, and a mixed cationic dye comprising several chromophores ... | 02/06/2007 |
| 7169805 | Captopril derivatives Captopril nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment or prophylaxis of cardiovascular, inflammatory and renal diseases. ... | 01/30/2007 |
| 7166583 | 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof The present invention relates to 1,3-diaza-dibenzoazulene derivatives, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of ... | 01/23/2007 |
| 7161010 | Methine compound and silver halide photographic material containing the same Disclosed is a compound represented by the following formula (I): wherein Z1 represents an atomic group necessary to form a 5- or 6-membered nitrogen-containing heterocyclic ring; Z2 represe... | 01/09/2007 |
| 7160485 | Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making Sulfoderivatives of perylenetetracarboxylic acid dibenzimidazole are provided. These compounds form liquid crystal systems possessing high quality optical properties. The resulting liquid crystal systems are readily applicable onto a substrate to obtain optically is... | 01/09/2007 |
| 7118811 | Materials for light emitting devices consisting of novel compounds and light emitting devices using the same A compound represented by formula (IA) or (IIA): wherein R11, R12 and R13 each represents a hydrogen atom, an aliphatic hydrocarbon group, an aryl group or a heterocyclic group; L... | 10/10/2006 |
| 7094901 | Expanded anionic compounds comprising hydroxyl or quiescent reactive functionality and catalyst activators therefrom A cocatalyst or cocatalyst component, including a compound corresponding to the formula: (A*+a)b(Z*J*j)−cd, wherein: A* is a cation of from 1 to 80 atoms, no... | 08/22/2006 |
| 6833455 | Bridged perinones/quinophthalones Disclosed herein are bridged perinones/quinophthalones of the general formula (I) or tautomeric forms thereof where X1, X2, Ar1 Ar2 and B are as described herein and are particularly characterized... | 12/21/2004 |
| 6703504 | Conformationally constrained compounds as dendrimer cores There are provided novel chemical compounds and their uses in the preparation of polymers and oligomers, and the preparation of such compounds. In certain embodiments there are provided dendritic polymers and oligomers, of a type having at least four poly... | 03/09/2004 |
| 6699899 | Substituted acylhydroxamic acids and method of reducing TNF levels Imido and amido substituted acylhydroxamic acids which reduce the levels of TNF and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propanoylamino)p ropanoate.... | 03/02/2004 |
| 6667405 | Methine compound and silver halide photographic material containing the same Disclosed is a compound represented by the following formula (I): ##STR1## wherein Z1 represents an atomic group necessary to form a 5- or 6-membered nitrogen-containing heterocyclic ring; Z2 represents an atomic group necessary to f... | 12/23/2003 |
| 6664283 | Pharmaceuticals for neurogenic pain This invention relates to pharmaceuticals for neuropathic pains comprising an mGluR1 receptor antagonist for systemic administration. Drugs efficacious in treating various neuropathic pain can be provided by the invention.... | 12/16/2003 |
| 6608098 | Isoindole derivatives This invention relates to compounds represented by the general formula [I] ##STR1## wherein, R represents an azido group, etc., R1 and R2 are the same or different and represent hydrogen atoms, etc., R3 and R4 are th... | 08/19/2003 |
| 6562981 | Benzo (4,5) imidazo (2,1-a) isoindol-11-ones A composition comprising (a) an effective amount of a guest chromophore embedded in a matrix of a host chromophore, or (b) a host chromophore and an effective amount of a guest chromophore both embedded in a polymer matrix, wherein the absorption spectrum... | 05/13/2003 |
| 6562964 | Heterocyclic compounds as inhibitors of rotamase enzymes Compounds of the formula (I): ##STR1## wherein A, Y, R, X, R1, R2, R3 and R4 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal r... | 05/13/2003 |
| 6462060 | Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use Compounds with heterocyclic-hydroxyimino-fluorene nuclei that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal tr... | 10/08/2002 |
| 6433182 | Nitrosated and nitrosylated -adrenergic receptor antagonist compounds, compositions and their uses The present invention is directed to nitrosated or nitrosylated -adrenergic receptor antagonists, compositions comprising -adrenergic receptor antagonists that are optionally substituted with at least one NO or NO2 moiety and comp... | 08/13/2002 |
| 6384284 | Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions A description is given of diphenyl compounds of formula ##STR1## wherein R is a camphor or hydantoin derivative; and R1 is hydrogen; or C1 -C5 alkyl. These compounds are suitable as light stabilizers in cosmetic, pharmaceutical... | 05/07/2002 |
| 6291447 | Granulatimide compounds and uses thereof Novel granulatimide compounds and pharmaceutical formulations thereof are provided. Compounds of this invention have the general formula: ##STR1## wherein are independently R or Z as defined below, or in combination F and F' is Ar1 as defined b... | 09/18/2001 |
| 6281355 | Nitrogen-containing tetracyclic compounds A nitrogen-containing tetracyclic compound represented by the formula: ##STR1## wherein Y1 --Y2 --Y3 is N--C.dbd.N or a group represented by the formula: C.dbd.C--NR3 (wherein R3 is a hydrogen atom, a ... | 08/28/2001 |
| 6255488 | Bicyclic amidines, process for their preparation, and their use as catalyst The process for the preparation of bicyclic amidines of the general formula: ##STR1## wherein A is selected from the group consisting of --CR1 R2 --CR3 R4 --CR5 R6 --, --CR1 R | 07/03/2001 |
| 6191157 | Hetero-linked phenylglycinolamides The hetero-linked phenylglycinolamides are prepared by reaction of the corresponding hetero-linked phenylacetic acids with appropriate phenylglycinols. The hetero-linked phenylglycinolamides are suitable as active compounds in medicaments.... | 02/20/2001 |
| 6166034 | Spiro piperidine derivatives as 5HT1D receptor antagonists Novel spiro piperdine derivatives of formula (I), in which P1, P2, R1, R2, R2 ', R3, m, A, E, G, X, Y, R7, R8, R9 and R10 have the meanings defined in... | 12/26/2000 |
| 6150520 | Process for the preparation of tetraazamacrocycles Procedures for preparing compounds of formula (I) ##STR1## in which n, p and q or independently 0 or 1, are prepared according to the reaction scheme: ##STR2##... | 11/21/2000 |
